• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活蛋白-1和高迁移率族蛋白-I(Y)在白细胞介素-1β诱导血管平滑肌细胞CD44基因表达中的作用

Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1beta in vascular smooth muscle cells.

作者信息

Foster L C, Wiesel P, Huggins G S, Pañares R, Chin M T, Pellacani A, Perrella M A

机构信息

Cardiovascular Biology Laboratory, Harvard School of Public Health, Boston, Massachusetts 02115, USA.

出版信息

FASEB J. 2000 Feb;14(2):368-78. doi: 10.1096/fasebj.14.2.368.

DOI:10.1096/fasebj.14.2.368
PMID:10657993
Abstract

CD44 is a multifunctional cell adhesion molecule that participates in pathological states such as inflammation and tumorigenesis. CD44 is induced on vascular smooth muscle cells after arterial wall injury and may mediate their proliferation and migration into the neointima during arteriosclerosis. We have demonstrated elsewhere that the proinflammatory cytokine interleukin (IL)-1beta up-regulates CD44 mRNA and protein expression in cultured rat aortic smooth muscle cells (RASMC) by increasing gene transcription. By transient transfection of 5'-deletion constructs into RASMC, we show in the present study that a conserved AP-1 site 110 base pairs from the transcription start site of the mouse CD44 promoter is important for basal activity. Mutation of the AP-1 site significantly reduced induction of promoter activity by IL-1beta, and electrophoretic mobility shift assays demonstrated that Fos and c-Jun were present in the CD44 AP-1 binding complex after IL-1beta stimulation. In addition, cotransfection of the architectural transcription factor high mobility group (HMG)-I(Y) protein with c-Fos and c-Jun markedly increased trans-activation of the CD44 promoter. Taken together, our studies demonstrate that AP-1 proteins are a central regulatory component used by IL-1beta to modulate expression of CD44 during an inflammatory response in vascular smooth muscle cells and that transcription of CD44 by AP-1 proteins is enhanced by HMG-I(Y). -Foster, L. C., Wiesel, P., Huggins, G. S, Pañares, R., Chin, M. T., Pellacani, A., Perrella, M. A. Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1beta in vascular smooth muscle cells.

摘要

CD44是一种多功能细胞黏附分子,参与炎症和肿瘤发生等病理状态。动脉壁损伤后,血管平滑肌细胞上会诱导产生CD44,在动脉硬化过程中,它可能介导平滑肌细胞的增殖和向新生内膜的迁移。我们在其他地方已经证明,促炎细胞因子白细胞介素(IL)-1β通过增加基因转录,上调培养的大鼠主动脉平滑肌细胞(RASMC)中CD44的mRNA和蛋白质表达。通过将5'-缺失构建体瞬时转染到RASMC中,我们在本研究中表明,小鼠CD44启动子转录起始位点上游110个碱基对处的一个保守AP-1位点对基础活性很重要。AP-1位点的突变显著降低了IL-1β对启动子活性的诱导,电泳迁移率变动分析表明,IL-1β刺激后,Fos和c-Jun存在于CD44的AP-1结合复合物中。此外,结构转录因子高迁移率族(HMG)-I(Y)蛋白与c-Fos和c-Jun共转染,显著增加了CD44启动子的反式激活。综上所述,我们的研究表明,AP-1蛋白是IL-1β在血管平滑肌细胞炎症反应中调节CD44表达所使用的核心调节成分,并且HMG-I(Y)增强了AP-1蛋白对CD44的转录。-福斯特,L.C.,维泽尔,P.,哈金斯,G.S,帕尼亚雷斯,R.,钦,M.T.,佩拉卡尼,A.,佩雷拉,M.A.激活蛋白-1和高迁移率族-I(Y)蛋白在白细胞介素-1β诱导血管平滑肌细胞CD44基因表达中的作用

相似文献

1
Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1beta in vascular smooth muscle cells.激活蛋白-1和高迁移率族蛋白-I(Y)在白细胞介素-1β诱导血管平滑肌细胞CD44基因表达中的作用
FASEB J. 2000 Feb;14(2):368-78. doi: 10.1096/fasebj.14.2.368.
2
High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer.高迁移率族-I(Y)蛋白促进核因子-κB与诱导型一氧化氮合酶启动子/增强子的结合及反式激活。
J Biol Chem. 1999 Mar 26;274(13):9045-52. doi: 10.1074/jbc.274.13.9045.
3
Regulation of CD44 gene expression by the proinflammatory cytokine interleukin-1beta in vascular smooth muscle cells.促炎细胞因子白细胞介素-1β对血管平滑肌细胞中CD44基因表达的调控
J Biol Chem. 1998 Aug 7;273(32):20341-6. doi: 10.1074/jbc.273.32.20341.
4
Regulation of IL-1-induced gingival collagenase gene expression by activator protein-1 (c-Fos/c-Jun).活化蛋白-1(c-Fos/c-Jun)对白细胞介素-1诱导的牙龈胶原酶基因表达的调控
Cytokine. 2000 Nov;12(11):1609-19. doi: 10.1006/cyto.2000.0676.
5
Oncostatin M stimulates c-Fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter.抑瘤素M刺激c-Fos与金属蛋白酶组织抑制剂-1启动子内的转录反应性AP-1元件结合。
J Biol Chem. 1998 Feb 27;273(9):5211-8. doi: 10.1074/jbc.273.9.5211.
6
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers.一个功能性激活蛋白1(AP-1)位点通过与JunB-Fra1和JunB-FosB异二聚体相互作用来调节心脏细胞的基质金属蛋白酶2(MMP-2)转录。
Biochem J. 2003 Feb 1;369(Pt 3):485-96. doi: 10.1042/BJ20020707.
7
Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase.内毒素和白细胞介素-1β诱导血管平滑肌细胞中高迁移率族蛋白-I(Y)的表达。其在诱导型一氧化氮合酶激活中的作用。
J Biol Chem. 1999 Jan 15;274(3):1525-32. doi: 10.1074/jbc.274.3.1525.
8
Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors.环磷酸腺苷(cAMP)和白细胞介素-1β对大鼠血管平滑肌细胞IIA 型磷脂酶A2基因的转录调控:CCAAT/增强子结合蛋白(C/EBP)、核因子-κB和Ets转录因子之间的相互作用
Biochem J. 2002 Dec 1;368(Pt 2):415-24. doi: 10.1042/BJ20020658.
9
AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells.激活蛋白-1参与尿苷三磷酸诱导的动脉平滑肌细胞骨桥蛋白表达。
Circ Res. 2003 Oct 3;93(7):674-81. doi: 10.1161/01.RES.0000094747.05021.62. Epub 2003 Sep 11.
10
Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.评估激活蛋白-1对小鼠类固醇生成急性调节蛋白基因转录的作用。
Mol Endocrinol. 2004 Mar;18(3):558-73. doi: 10.1210/me.2003-0223. Epub 2003 Dec 12.

引用本文的文献

1
Pathology-oriented multiplexing enables integrative disease mapping.面向病理学的多重分析可实现综合疾病图谱绘制。
Nature. 2025 Jul 18. doi: 10.1038/s41586-025-09225-2.
2
Fra-2 overexpression upregulates pro-metastatic cell-adhesion molecules, promotes pulmonary metastasis, and reduces survival in a spontaneous xenograft model of human breast cancer.Fra-2 过表达上调促转移细胞黏附分子,促进肺转移,并降低人乳腺癌自发异种移植模型中的存活率。
J Cancer Res Clin Oncol. 2022 Jun;148(6):1525-1542. doi: 10.1007/s00432-021-03812-2. Epub 2021 Oct 24.
3
Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays.
眼基因治疗临床试验和转基因表达及生物活性测定中的重组腺相关病毒载体(rAAV)-载体元件。
Int J Mol Sci. 2020 Jun 12;21(12):4197. doi: 10.3390/ijms21124197.
4
Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links.2型糖尿病与心血管疾病:遗传和表观遗传联系
Front Endocrinol (Lausanne). 2018 Jan 17;9:2. doi: 10.3389/fendo.2018.00002. eCollection 2018.
5
Transforming growth factor β1 (TGFβ1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts.转化生长因子β1(TGFβ1)通过细胞外信号调节激酶(ERK)诱导的早期生长反应蛋白1(EGR1)来调节肺纤维化成纤维细胞中CD44V6的表达和活性。
J Biol Chem. 2017 Jun 23;292(25):10465-10489. doi: 10.1074/jbc.M116.752451. Epub 2017 Apr 7.
6
The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.癌症与发育过程中的高迁移率族蛋白A1(HMGA1)转录组
Curr Mol Med. 2016;16(4):353-93. doi: 10.2174/1566524016666160316152147.
7
Deletion of Hyaluronan Synthase 3 Inhibits Neointimal Hyperplasia in Mice.透明质酸合酶3缺失抑制小鼠血管内膜增生。
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):e9-16. doi: 10.1161/ATVBAHA.115.306607. Epub 2015 Nov 19.
8
Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.靶向去势抵抗性前列腺癌中的癌症干细胞
Clin Cancer Res. 2016 Feb 1;22(3):670-9. doi: 10.1158/1078-0432.CCR-15-0190. Epub 2015 Oct 21.
9
Specific tools for targeting and expression in Müller glial cells.针对 Müller 胶质细胞的靶向和表达的特定工具。
Mol Ther Methods Clin Dev. 2014 Mar 19;1:14009. doi: 10.1038/mtm.2014.9. eCollection 2014.
10
Hitting the bull's eye: targeting HMGA1 in cancer stem cells.正中靶心:靶向癌症干细胞中的HMGA1
Expert Rev Anticancer Ther. 2014 Jan;14(1):23-30. doi: 10.1586/14737140.2013.859988.